Trademark: 79311676
Word
CCURE API
Status
Registered
Status Code
700
Status Date
Tuesday, May 24, 2022
Serial Number
79311676
Registration Number
6720837
Registration Date
Tuesday, May 24, 2022
Mark Type
3000
Filing Date
Monday, March 8, 2021
Published for Opposition
Tuesday, February 22, 2022

Trademark Owner History
SELECTCHEMIE AG - Original Registrant
LABORATORIOS ESPINOS Y BOFILL, S.A. - Original Registrant

Classifications
5 Pharmaceutical and veterinary products, namely, pharmaceutical preparations for treating digestive disorders and parasitic infections; hygienic and sanitary products for medical use, namely antibiotic ointments and wound dressings
1 Active chemical ingredients for use in the manufacture of pharmaceutical substances for the treatment of diseases or infections pertaining to the following therapeutic areas: Alimentary tract and metabolism , Autoimmune, Bone/ Osteosporosis, Cardiovascular, Central Nervous System, Diabetes, Diagnostic agents, Genito urinary, Inmunology, Endocrine, Gastroenterology, Haematology, Infectious, Inflammation, Internal disease, Mental Health or Psychiatry, Musculo-skeletal system, Neurology, Oncology, Orthopaedics , Pulmonology, Respiratory, Rheumatology, Sensory Organs
The mark consists of the wording "CCURE API", with the first letter "C" and the term "API" appear in green, and the letters "CURE" appearing in blue, all appearing within a blue hexagonal carrier. The color white merely indicates background and is not claimed as a feature of the mark.
The color(s) blue and green is/are claimed as a feature of the mark.
"CURE API"

Trademark Events
Sep 9, 2022
Generic Madrid Transaction Sent To Ib
Sep 9, 2022
Generic Madrid Transaction Created
Aug 24, 2022
Final Disposition Notice Created, To Be Sent To Ib
May 24, 2022
Notice Of Registration Confirmation Emailed
May 24, 2022
Registered-Principal Register
Feb 22, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 22, 2022
Published For Opposition
Feb 20, 2022
Notification Processed By Ib
Feb 2, 2022
Notification Of Possible Opposition Sent To Ib
Feb 2, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 2, 2022
Notification Of Notice Of Publication E-Mailed
Jan 19, 2022
Assigned To Lie
Jan 19, 2022
Approved For Pub - Principal Register
Jan 19, 2022
Examiner's Amendment Entered
Jan 19, 2022
Notification Of Examiners Amendment E-Mailed
Jan 19, 2022
Examiners Amendment E-Mailed
Jan 19, 2022
Examiners Amendment -Written
Jan 4, 2022
Teas/Email Correspondence Entered
Jan 3, 2022
Correspondence Received In Law Office
Jan 3, 2022
Teas Response To Office Action Received
Dec 6, 2021
Refusal Processed By Ib
Nov 16, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Nov 16, 2021
Refusal Processed By Mpu
Nov 12, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Nov 11, 2021
Non-Final Action Written
Nov 9, 2021
Assigned To Examiner
Sep 29, 2021
Assigned To Examiner
Jun 1, 2021
Application Filing Receipt Mailed
May 28, 2021
New Application Office Supplied Data Entered In Tram
May 27, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24